Диффузионно-взвешенные изображения при очаговой патологии печени: обзор литературы
Аннотация
Об авторах
Карина Хусаиновна ЛомовцеваРоссия
Григорий Григорьевич Кармазановский
Россия
Список литературы
1. Demir O.I., Obuz F., Sağol O., Dicle O. Contribution of diffusion-weighted MRI to the differential diagnosis of hepatic masses. Diagn. Interv. Radiol. 2007; 13 (2): 81-86.
2. Chandarana H., Taouli B. Diffusion and perfusion imaging of the liver. Eur. J. Radiol. 2010; 76 (3): 348-358.
3. Semelka R.C., Martin D.R., Balci C., Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J. Magn. Reson. Imaging. 2001; 13 (3): 397-401.
4. Galea N., Cantisani V., Taouli B. Liver lesion detection and characterization: role of diffusion-weighted imaging. J. Magn. Reson. Imaging. 2013; 37 (6): 1260-1276.
5. Le Bihan D., Breton E., Lallemand D. et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986; 161 (2): 401-407.
6. Schaefer P.W., Grant P.E., Gonzalez R.G. Diffusionweighted MR imaging of the brain. Radiology. 2000; 217 (2): 331-345.
7. Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am. J. Roentgenol. 2007; 188 (6): 1622-1635.
8. Kanematsu M., Goshima S., Watanabe H. et al. Diffusion/perfusion MR imaging of the liver: practice, challenges, and future. Magn. Reson. Med. Sci. 2012; 11 (3): 151-161.
9. Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics. 2009; 29 (6): 1797-1810.
10. Taouli B., Koh D.M. Diffusion-weighted MR imaging of the liver. Radiology. 2010; 254 (1): 47-66.
11. Акчурина Э.Д. Диффузионно-взвешенные изображения в комплексной лучевой диагностике очаговых поражений печени: Дис. ... канд. мед. наук. М., 2011. 24 с.
12. Papanikolaou N., Gourtsoyianni S., Yarmenitis S. et al. Comparison between two-point and four-point methods for quantification of apparent diffusion coefficient of normal liver parenchyma and focal lesions. Value of normalization with spleen. Eur. J. Radiol. 2010; 73 (2): 305-309.
13. Goshima S., Kanematsu M., Kondo H. et al. Diffusionweighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J. Magn. Reson. Imaging. 2008; 28 (3): 691-697.
14. Aslan K., Danaci M., Polat A.V. et al. Can a b value of 500 be substituted for a b value of 1000 in the characterization of focal liver lesions? Abdom. Imaging. 2014; 39 (2): 300-309.
15. Kandpal H., Sharma R., Madhusudhan K.S., Kapoor K.S. Respiratory-triggered versus breath-hold diffusionweighted MRI of liver lesions: comparison of image quality and apparent diffusion coefficient values. Am. J. Roentgenol. 2009; 192 (4): 915-922.
16. Kim S.Y., Lee S.S., Byun J.H. et al. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology. 2010; 255 (3): 815-823.
17. Chiu F.Y., Jao J.C., Chen C.Y. et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J. Comput. Assist. Tomogr. 2005; 29 (2): 176-180.
18. Choi J.S., Kim M.J., Choi J.Y. et al. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur. Radiol. 2010; 20 (5): 1052-1060.
19. Benndorf M., Schelhorn J., Dietzel M. et al. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Eur. J. Radiol. 2012; 81 (8): e849-е853.
20. Muhi A., Ichikawa T., Motosugi U. et al. Diffusion- and T2-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium. Magn. Reson. Med. Sci. 2012; 11 (3): 185-191.
21. Bruegel M., Gaa J., Waldt S. et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusionweighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. Am. J. Roentgenol. 2008; 191 (5): 1421-1429.
22. Parikh T., Drew S.J., Lee V.S. et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology. 2008; 246 (3): 812-822.
23. Zech C.J., Herrmann K.A., Dietrich O. et al. Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest. Radiol. 2008; 43 (4): 261-266.
24. Kim T., Murakami T., Takahashi S. et al. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. Am. J. Roentgenol. 1999; 173 (2): 393-398.
25. Taouli B., Vilgrain V., Dumont E. et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology. 2003; 226 (1): 71-78.
26. Demir O.I., Obuz F., Sağol O., Dicle O. Contribution of diffusion-weighted MRI to the differential diagnosis of hepatic masses. Diagn. Interv. Radiol. 2007; 13 (2): 81-86.
27. Bruegel M., Holzapfel K., Gaa J. et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur. Radiol. 2008; 18 (3): 477-485.
28. Gourtsoyianni S., Papanikolaou N., Yarmenitis S. et al. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur. Radiol. 2008; 18 (3): 486-492.
29. Miller F.H., Hammond N., Siddiqi A.J. et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J. Magn. Reson. Imaging. 2010; 32 (1): 138-147.
30. Testa M.L., Chojniak R., Sene L.S. et al. Is DWI/ADC a useful tool in the characterization of focal hepatic lesions suspected of malignancy? PLoS One. 2014; 9 (7): e101944.
31. Holzapfel K., Bruegel M., Eiber M. et al. Characterization of small (≤10 mm) focal liver lesions: value of respiratorytriggered echo-planar diffusion-weighted MR imaging. Eur. J. Radiol. 2010; 76 (1): 89-95.
32. Koike N., Cho A., Nasu K. et al. Role of iffusion-weighted agnetic resonance imaging in the differential diagnosis of focal hepatic lesions. Wld J. Gastroenterol. 2009; 15 (46): 5805-5812.
33. Nam S.J., Park K.Y., Yu J.S. et al. Hepatic cavernous hemangiomas: relationship between speed of intratumoral enhancement during dynamic MRI and apparent diffusion coefficient on diffusion-weighted imaging. Korean J. Radiol. 2012; 13 (6): 728-735.
34. Sandrasegaran K., Akisik F.M., Lin C. et al. The value of diffusion-weighted imaging in characterizing focal liver masses. Acad. Radiol. 2009; 16 (10): 1208-1214.
35. Sutherland T., Steele E., van Tonder F., Yap K. Solid focal liver lesion characterization with apparent diffusion coefficient ratios. J. Med. Imaging Radiat. Oncol. 2014; 58 (1): 32-37.
36. Onur M.R., Çiçekçi M., Kayalı A. et al. The role of ADC measurement in differential diagnosis of focal hepatic lesions. Eur. J. Radiol. 2012; 81 (3): e171-e176.
37. Latif M.A., Hawary G.E., Badrawy A.E., Alfy H.E. The role of MR diffusion in differentiation of malignant and benign hepatic focal lesions. Egypt J. Radiol. Nucl. Medicine. 2014; 45 (2): 299-308.
38. Agnello F., Ronot M., Valla D.C. et al. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology. 2012; 262 (2): 511-519.
39. Schmid-Tannwald C., Jiang Y., Dahi F. et al. Diffusionweighted MR imaging of focal liver lesions in the left and rightlobes: is there a difference in ADC values? Acad. Radiol. 2013; 20 (4): 440-445.
40. Hardie A.D., Naik M., Hecht E.M. et al. Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur. Radiol. 2010; 20 (6): 1431-1441.
41. Kenis C., Deckers F., De Foer B. et al. Diagnosis of liver metastases: can diffusion-weighted imaging (DWI) be used as a stand alone sequence? Eur. J. Radiol. 2012; 81 (5): 1016-1023.
42. Eiber M., Fingerle A.A., Brügel M. et al. Detection and classification of focal liver lesions in patients with colorectal cancer: retrospective comparison of diffusion-weighted MR imaging and multi-slice CT. Eur. J. Radiol. 2012; 81 (4): 683-691.
43. Holzapfel K., Reiser-Erkan C., Fingerle A.A. et al. Com parison of diffusion-weighted MR imaging and multidetectorrow CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom. Imaging. 2011; 36 (2): 179-184.
44. Koh D.M., Brown G., Riddell A.M. et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur. Radiol. 2008; 18 (5): 903-910.
45. Koh D.M., Collins D.J., Wallace T. et.al. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br. J. Radiol. 2012; 85 (1015): 980-989.
46. Holzapfel K., Eiber M.J., Fingerle A.A. et al. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acidenhanced MR imaging and the combination of both methods. Abdom. Imaging. 2012; 37 (1): 74-82.
47. Löwenthal D., Zeile M., Lim W.Y. et al. Detection and characterization of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur. Radiol. 2011; 21 (4): 832-840.
48. Haratake J., Takeda S., Kasai T. et al. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma. Cancer. 1993; 72 (4): 1178-1183.
49. Nzeako U.C., Goodman Z.D., Ishak K.G. Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer. 1995; 76 (4): 579-588.
50. De Carlis L., Giacomoni A., Lauterio A. et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl. Int. 2003; 16 (2): 115-122.
51. Bhattacharjya S., Bhattacharjya T., Quaglia A. et al. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators. Dig. Surg. 2004; 21 (2): 152-159.
52. Pérez-Saborido B., de los Galanes S.J., Menéu-Díaz J.C. et al. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors. Transplant. Proc. 2007; 39 (7): 2304-2307.
53. Oishi K., Itamoto T., Amano H. et al. Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J. Surg. Oncol. 2007; 95 (4): 311-316.
54. Okusaka T., Okada S., Ueno H. et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer. 2002; 95 (9): 1931-1937.
55. Nasu K., Kuroki Y., Tsukamoto T. et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histo pathologic grade. Am. J. Roentgenol. 2009; 193 (2): 438-444.
56. Nishie A., Tajima T., Asayama Y. et al. Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma. Eur. J. Radiol. 2011; 80 (2): e29-e33.
57. Piana G., Trinquart L., Meskine N. et al. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J. Hepatol. 2011; 55 (1): 126-132.
58. Muhi A., Ichikawa T., Motosugi U. et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J. Magn. Reson. Imaging. 2009; 30 (5): 1005-1011.
59. Asayama Y., Yoshimitsu K., Nishihara Y. et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. Am. J. Roentgenol. 2008; 190 (1): W28-34.
60. Vandecaveye V., De Keyzer F., Verslype C. et al. Diffusionweighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur. Radiol. 2009; 19 (10): 2456-2466.
61. Mori Y., Tamai H., Shingaki N. et al. Detection of hypervascular hepatocellular carcinoma with non-enhanced magnetic resonance imaging including diffusion-weighted imaging. GHR. 2013; 2 (3): 473-478.
62. Xu P.J., Yan F.H., Wang J.H. et al. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrastenhanced MRI alone using receiver operating characteristic curve analysis. J. Magn. Reson. Imaging. 2009; 29 (2): 341-349.
63. Zhao X.T., Li W.X., Chai W.M., Chen K.M. Detection of small hepatocellular carcinoma using gadoxetic acidenhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial? J. Dig. Dis. 2014; 15 (3): 137-145.
64. Cui Y., Zhang X.P., Sun Y.S. et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology. 2008; 248 (3): 894-900.
65. Koh D.M., Scurr E., Collins D. et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. Am. J. Roentgenol. 2007; 188 (4): 1001-1008.
66. Marugami N., Tanaka T., Kitano S. et al. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging. Cardiovasc. Intervent. Radiol. 2009; 32 (4): 638-646.
67. Sangiovanni A., Del Ninno E., Fasani P. et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 2004; 126 (4):1005-1014.
68. Chung J.C., Naik N.K., Lewandowski R.J. et al. Diffusionweighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. Wld J. Gastroenterol. 2010; 16 (25): 3161-3167.
69. Yuan Z., Ye X.D., Dong S. et al. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma. Eur. J. Radiol. 2010; 75 (1): e9-е14.
70. Mannelli L., Kim S., Hajdu C.H. et al. Serial diffusionweighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Eur. J. Radiol. 2013; 82 (4): 577-582.
71. Mungai F., Pasquinelli F., Mazzoni L.N. et al. Diffusionweighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases. Radiol. Med. 2014; 119 (8): 625-633.
72. Dudeck O., Zeile M., Wybranski C. et al. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur. Radiol. 2010; 20 (11): 2699-2706.
73. Goshima S., Kanematsu M., Kondo H. et al. Evaluating local hepatocellular carcinoma recurrence posttranscatheter arterial chemoembolization: is diffusionweighted MRI reliableas an indicator? J. Magn. Reson. Imaging. 2008; 27 (4): 834-839.
74. Yu J.S., Kim J.H., Chung J.J., Kim K.W. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after hemoembolization of hepatocellular carcinomas. J. Magn. Reson. Imaging. 2009; 30 (1): 153-160.
Рецензия
Для цитирования:
Ломовцева К.Х., Кармазановский Г.Г. Диффузионно-взвешенные изображения при очаговой патологии печени: обзор литературы. Медицинская визуализация. 2015;(6):50-60.
For citation:
Lomovtseva K.Kh., Karmazanovsky G.G. Diffusion-Weighted Imaging of Focal Liver Lesions: Literature Review. Medical Visualization. 2015;(6):50-60. (In Russ.)